Primary rhabdomyosarcoma of the breast in a 13-year-old girl: report of a case.

Department of Breast and Endocrine Surgery, Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Tokyo 105-8461, Japan.
Surgery Today (Impact Factor: 1.21). 02/2007; 37(1):38-42. DOI: 10.1007/s00595-006-3326-2
Source: PubMed

ABSTRACT We report a case of primary alveolar rhabdomyosarcoma of the breast in a 13-year-old Japanese girl. The patient initially presented with a 13 x 8-cm mass in her left breast, which was diagnosed as alveolar rhabdomyosarcoma after an excisional biopsy. Genetic expression of the tumor revealed t(2;13)(q35-37;q14). She underwent modified radical mastectomy (Bt + Ax) and nine lymph nodes were found to be involved. Systemic examinations showed multiple bone and lung metastases 2 weeks after her operation. Despite chemotherapy with doxorubicin, ifosfamide, and actinomycin D, which resulted in remission for 6 months, she died of the disease 8 months after surgery.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Rhabdomyosarcoma and schwannoma are two of the rarer tumors seen in the surgical setting, and it is rarer still to see these tumors originate in the breast. Rhabdomyosarcoma has an incidence of only 250 cases a year in the United States; of these, more than 90% are seen in individuals 25 years and younger. To our knowledge, only 24 cases of primary breast schwannoma have been reported in the English literature to date. Here, we present the cases of two perimenopausal women who presented with a primary rhabdomyosarcoma and a primary schwannoma at a small community hospital in central Florida within a period of less than three years. These cases provide an interesting juxtaposition to the management of typical breast cancer. Through proper evaluation, such cases can be treated without need of referral to a tertiary center, despite the extreme rarity of their conditions.
    Southern medical journal 10/2010; 103(12):1235-7. DOI:10.1097/SMJ.0b013e3181f3d73b · 1.12 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Primary alveolar type of rhabdomyosarcoma (RMS) tumor tissue was collected from the tongue of a 17-year-old Japanese woman and used to successfully establish a rhabdomyosarcoma cell line, which has been designated NUTOS. The chromosomal distribution revealed that the NUTOS cell line was hyper-tetraploid with chromosomal translocation. The cells were grown in Dulbecco's modified eagle medium/F12 supplemented with 15% fetal bovine serum, 0.1% non-essential amino acids solution (NEAA), 50 microg of streptomycin, 50 U/mL of penicillin and 0.25 microg /mL of Fungizone. The NUTOS shapes included small spindles, large spindles and long, thick multinucleated cells. All three cell types were immunostained with anti-desmin antibody, which is a marker protein for middle sized myofilaments. Furthermore, immunocytochemical staining revealed that the cells were positively immunostained with anti-MyoD, myogenin, alpha-sarcomeric actin, myosin and troponin T. Mitotic figures were only observed in the small spindle cells. These cells were coadunated with each other at the lateral portion of the apex of the cells. Subsequently, these cells grew into large multinucleated cells. Autonomic contractions (approximately 20 times/min) were observed in both the large spindle cells and the large multinucleated cells. NUTOS cells incorporated serotonin from the serum in the growth medium. Histopathological observations of the NUTOS cell grafts in the subcutis of nude mice exhibited characteristics similar to those seen for the primary rhabdomyosarcoma of the tongue. Susceptibility tests for the anti-cancer drugs revealed that NUTOS cells were susceptive to cisplatin, paclitaxel, and docetaxel, but not to adriacin.
    Human Cell 05/2010; 23(2):65-73. DOI:10.1111/j.1749-0774.2010.00086.x · 1.74 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Breast metastasis from rhabdomyosarcoma (RMS) is an uncommon event but may be problematic in treatment decision-making. Aim of the study was to evaluate clinical characteristics, treatment, and subsequent outcome, of patients with RMS metastasis in the breast, enrolled in four consecutive Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) Soft Tissue Sarcoma Committee protocols during the last 20 years, in order to obtain information to establish a more adequate diagnostic and therapeutic approach. Data were derived from the AIEOP STSC database and reviewed for the purpose of this study. From 1988 to 2008, among 189 patients with metastatic RMS, we identified 7 (3.7%) patients with RMS with breast involvement at diagnosis. All patients were females, aged 13-17 years with alveolar histology and multiple metastasis sites (2-5). The primary tumor was located in the extremities in 3/7 patients. In spite of intensive treatment no patient survived. The cause of treatment failure was distant relapse in six patients, including two on the mammary region. Treatment data analysis revealed that local measures to control breast lesions were used in only two patients. Our data suggest that investigations of the mammary region should be part of the usual diagnostic workup in adolescent girls with alveolar RMS, especially if the primary tumor arises in the extremities. New and more effective strategies are needed to improve the outcome of these patients including aggressive local measures to control breast disease.
    Pediatric Blood & Cancer 12/2010; 55(7):1306-9. DOI:10.1002/pbc.22729 · 2.56 Impact Factor